Skip to content

Investigating the role of salt inducible kinases in atherosclerosis

Investigating the role of salt inducible kinases in atherosclerosis: a observational cross-sectional study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN14632677
Enrollment
90
Registered
2016-06-28
Start date
2016-08-01
Completion date
Unknown
Last updated
2020-11-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

STEMI, peripheral arterial disease Circulatory System

Interventions

Three groups will be evaluated in this study: Group 1. 10 patients with peripheral vascular disease (PVD) undergoing elective amputation. These patients will undergo blood sampling an

Sponsors

NHS Tayside/University of Dundee
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: PVD: 1. Age between 18-70 years 2. Admitted for elective amputation for PVD 3. Able to give written informed consent STEMI: 4. Age between 18-70 years 5. Admitted to CCU for STEMI and undergone PPCI 6. Able to give written informed consent Healthy volunteers: 7. Age between 18-70 years 8. No current or previous significant medical illness 9. Able to give written informed consent

Exclusion criteria

Exclusion criteria: Healthy volunteers: 1. Positive medical history of: 1.1. Vascular diseases such as peripheral arterial disease, stroke, IHD... etc 1.2. Haematological conditions such as hypercoagulability, deep venous thrombosis... etc 1.3. Hypertension 2. Alcohol excess 3. Unable to give written informed consent STEMI/PVD: Unable to give written informed consent

Design outcomes

Primary

MeasureTime frame
Serum levels of inflammatory cytokines taken at the time of operation in PVD group, 48-72 hours after PCI in STEMI group and at the time of assessment in healthy volunteers.

Secondary

MeasureTime frame
1. Tissue SIK levels in PVD patients at the time of surgery 2. Arterial stiffness and flow mediated dilatation in STEMI patients at 48-72 hours and in healthy volunteers at the time of assessment

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026